EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

AM Vannucchi, Peter te Boekhorst, CN Harrison, GS He, M Caramella, D Niederwieser, F Boyer-Perrard, MH Duan, N Francillard, B Molloy, M Wroclawska, H Gisslinger

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
1 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)947-954
Number of pages8
Issue number5
Publication statusPublished - 2019

Cite this